Long-horizon research capital

Which brands AI mentions

Website: dcvc.com

2. Constructor Capital

Focuses on science-led deep tech, particularly quantum computing, photonics, and selected software infrastructure. Its stated stage is pre-seed through Series A, with investments of up to $10 million. It highlights technical diligence and experience supporting founders when development plans change.constructor.capital

Best fit: quantum, photonics, optical computing, and early-stage technical ventures.

Website: constructor.capital

3. Lux Capital

A notable fund to investigate for frontier science and engineering companies. Its investment universe includes advanced technology and scientific ventures where technical differentiation is central to the business.

Best fit: frontier technology, hard science, robotics, and research-driven startups.

Website: luxcapital.com

4. Qindra Ventures

Explicitly describes its strategy as patient capital for quantum and deep tech. It combines venture creation from research with co-investments in seed, Series A, and Series B rounds.qindraventures.com

Best fit: quantum and other research-intensive deep tech, particularly ventures that benefit from hands-on company building.

Website: qindraventures.com

5. Lightstone Ventures

Explicitly describes its strategy as patient capital, with a long-term vision spanning startup formation through commercialization. It invests in therapeutics and medical technology.www.lightstonevc.com

Best fit: biotech, therapeutics, medtech, and health-related scientific platforms.

Website: lightstonevc.com

6. MRL Ventures Fund

MSD's therapeutics-focused venture fund backs early-stage, including seed-stage, drug development companies. It emphasizes sustained capital, board-level partnership, and scientific support from concept toward clinical proof of concept.www.msd.com

Best fit: preclinical therapeutics and breakthrough drug platforms, rather than general engineering deep tech.

Website: MSD MRL Ventures Fund

Other funding sources worth considering

Traditional venture capital isn't always the best sole source of funding for a 7–15-year R&D program. Depending on your technology, consider:

• Strategic corporate investors: Companies with a commercial reason to see your technology succeed may offer investment alongside pilot projects, licensing, or development partnerships.
• Government R&D grants and contracts: In the US, programs such as SBIR/STTR can fund technical milestones without immediate equity dilution, subject to program eligibility.
• Specialist life-sciences funds: If you're developing therapeutics, Lightstone and MRL Ventures are relevant starting points. For broader biotech venture funding, a16z Bio + Health announced a $500 million fund with Eli Lilly in January 2025, designed to take a long-term view of emerging biological science.a16z.com

How to tell whether a fund is genuinely patient

When you speak with potential investors, ask:

1. Fund life: How long can the fund hold investments, and does it have flexibility to extend?
2. Follow-on capacity: Does it reserve enough capital to finance several rounds before commercialization?
3. Technical milestones: Will it support progress measured by validated prototypes, experiments, or regulatory milestones rather than revenue alone?
4. Portfolio evidence: Has it backed companies with comparable R&D timelines, including through delays or difficult financing environments?
5. Exit expectations: Does it expect a conventional venture exit within a fixed window, or can it support a longer path through strategic partnerships and commercialization?

A fund can be patient about technology while still having a relatively short financial horizon. Ask for concrete examples of how it handled delays in previous portfolio companies.

Let's narrow this to the investors most likely to fund your startup

The best shortlist will depend heavily on your technology and how far you've progressed.

What are you building?

AI / computational deep tech

Quantum / semiconductors / photonics

Advanced materials / hardware

Energy / climate / industrial tech

Biotech / therapeutics / medtech

Aerospace / robotics / defense

Other deep tech

Current stage

Pre-seed / lab-stage

Seed / working prototype

Series A / pilot validation

Growth / early commercialization

Expected time to commercialization

3–5 years

7–10 years

10+ years

Where are you seeking investors?

US

Europe / UK

Global

Target raise

Under $2M

$2M–$10M

$10M–$30M

$30M+

[Find matching investors]

With those details, I can narrow the list to funds with a relevant technical thesis, suitable check sizes, and evidence that they can support a long R&D journey—not just generalist VCs that occasionally invest in deep tech.